Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.
The report details the trend, potential and market size of Insulin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Insulinmarket, defines the market attractiveness level of Insulin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Insulin industry, describes the types of Insulin market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insulin market and the development prospects and opportunities of Insulin industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insulin market in Chapter 13.
By Player:
Dongbao
Salix Pharmaceuticals
Novo Nordisk
Merck
Bioton
Henan Tian Fang Pharmaceutical
Bristol-Myers Squibb
Shihuida PHARMA Group
Boehringer Ingelheim
Novartis
Sanofi
GEA
Eli Lilly
United Laboratories (TUL)
Emisphere
MannKind
Takeda Pharmaceutical Company
Gan & Lee
Disha Pharmaceutical Group
By Type:
Ultra-short-acting insulin
Short-acting insulin
In effect insulin
Long-acting insulin
By End-User:
Type 1 diabetes
Type 2 diabetes
Others diabetes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Insulin Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Insulin Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Insulin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Insulin Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Insulin Market Analysis and Outlook to 2022
-
7.1 Global Insulin Consumption (2017-2022)
-
7.2 United States Insulin Consumption (2017-2022)
-
7.3 Europe Insulin Consumption (2017-2022)
-
7.4 China Insulin Consumption (2017-2022)
-
7.5 Japan Insulin Consumption (2017-2022)
-
7.6 India Insulin Consumption (2017-2022)
-
7.7 South Korea Insulin Consumption (2017-2022)
8 Region and Country-wise Insulin Market Analysis and Outlook to 2028
-
8.1 Global Insulin Consumption Forecast (2022-2028)
-
8.2 United States Insulin Consumption Forecast (2022-2028)
-
8.3 Europe Insulin Consumption Forecast (2022-2028)
-
8.4 China Insulin Consumption Forecast (2022-2028)
-
8.5 Japan Insulin Consumption Forecast (2022-2028)
-
8.6 India Insulin Consumption Forecast (2022-2028)
-
8.7 South Korea Insulin Consumption Forecast (2022-2028)
9 Global Insulin Market Outlook by Types and Applications to 2022
-
9.1 Global Insulin Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ultra-short-acting insulin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Short-acting insulin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global In effect insulin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Long-acting insulin Consumption and Growth Rate (2017-2022)
-
9.2 Global Insulin Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Type 1 diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Type 2 diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others diabetes Consumption and Growth Rate (2017-2022)
10 Global Insulin Market Outlook by Types and Applications to 2028
-
10.1 Global Insulin Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ultra-short-acting insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Short-acting insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global In effect insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Long-acting insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Insulin Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Type 1 diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Type 2 diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others diabetes Consumption Forecast and Growth Rate (2022-2028)
11 Global Insulin Import and Export Analysis (Top 5 Countries)
-
11.1 Global Insulin Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Insulin Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Insulin Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Insulin Market Competitive Analysis
-
14.1 Dongbao
-
14.1.1 Dongbao Company Details
-
14.1.2 Dongbao Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dongbao Insulin Product and Service
-
14.2 Salix Pharmaceuticals
-
14.2.1 Salix Pharmaceuticals Company Details
-
14.2.2 Salix Pharmaceuticals Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Salix Pharmaceuticals Insulin Product and Service
-
14.3 Novo Nordisk
-
14.3.1 Novo Nordisk Company Details
-
14.3.2 Novo Nordisk Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novo Nordisk Insulin Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Insulin Product and Service
-
14.5 Bioton
-
14.5.1 Bioton Company Details
-
14.5.2 Bioton Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bioton Insulin Product and Service
-
14.6 Henan Tian Fang Pharmaceutical
-
14.6.1 Henan Tian Fang Pharmaceutical Company Details
-
14.6.2 Henan Tian Fang Pharmaceutical Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Henan Tian Fang Pharmaceutical Insulin Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Insulin Product and Service
-
14.8 Shihuida PHARMA Group
-
14.8.1 Shihuida PHARMA Group Company Details
-
14.8.2 Shihuida PHARMA Group Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shihuida PHARMA Group Insulin Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Insulin Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Insulin Product and Service
-
14.11 Sanofi
-
14.11.1 Sanofi Company Details
-
14.11.2 Sanofi Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sanofi Insulin Product and Service
-
14.12 GEA
-
14.12.1 GEA Company Details
-
14.12.2 GEA Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 GEA Insulin Product and Service
-
14.13 Eli Lilly
-
14.13.1 Eli Lilly Company Details
-
14.13.2 Eli Lilly Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Eli Lilly Insulin Product and Service
-
14.14 United Laboratories (TUL)
-
14.14.1 United Laboratories (TUL) Company Details
-
14.14.2 United Laboratories (TUL) Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 United Laboratories (TUL) Insulin Product and Service
-
14.15 Emisphere
-
14.15.1 Emisphere Company Details
-
14.15.2 Emisphere Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Emisphere Insulin Product and Service
-
14.16 MannKind
-
14.16.1 MannKind Company Details
-
14.16.2 MannKind Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 MannKind Insulin Product and Service
-
14.17 Takeda Pharmaceutical Company
-
14.17.1 Takeda Pharmaceutical Company Company Details
-
14.17.2 Takeda Pharmaceutical Company Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Takeda Pharmaceutical Company Insulin Product and Service
-
14.18 Gan & Lee
-
14.18.1 Gan & Lee Company Details
-
14.18.2 Gan & Lee Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Gan & Lee Insulin Product and Service
-
14.19 Disha Pharmaceutical Group
-
14.19.1 Disha Pharmaceutical Group Company Details
-
14.19.2 Disha Pharmaceutical Group Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Disha Pharmaceutical Group Insulin Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Insulin
-
Figure Insulin Picture
-
Table Global Insulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insulin Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Insulin Consumption by Country (2017-2022)
-
Figure United States Insulin Consumption and Growth Rate (2017-2022)
-
Table Europe Insulin Consumption and Growth Rate (2017-2022)
-
Figure China Insulin Consumption and Growth Rate (2017-2022)
-
Figure Japan Insulin Consumption and Growth Rate (2017-2022)
-
Figure India Insulin Consumption and Growth Rate (2017-2022)
-
Figure South Korea Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption Forecast by Country (2022-2028)
-
Figure United States Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ultra-short-acting insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Short-acting insulin Consumption and Growth Rate (2017-2022)
-
Figure Global In effect insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Long-acting insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Others diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Ultra-short-acting insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Short-acting insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In effect insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-acting insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Insulin Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Insulin Export by Region (Top 5 Countries) (2017-2028)
-
Table Dongbao (Foundation Year, Company Profile and etc.)
-
Table Dongbao Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongbao Insulin Product and Service
-
Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Salix Pharmaceuticals Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Salix Pharmaceuticals Insulin Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Insulin Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Insulin Product and Service
-
Table Bioton (Foundation Year, Company Profile and etc.)
-
Table Bioton Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioton Insulin Product and Service
-
Table Henan Tian Fang Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Henan Tian Fang Pharmaceutical Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Henan Tian Fang Pharmaceutical Insulin Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Insulin Product and Service
-
Table Shihuida PHARMA Group (Foundation Year, Company Profile and etc.)
-
Table Shihuida PHARMA Group Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shihuida PHARMA Group Insulin Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Insulin Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Insulin Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Insulin Product and Service
-
Table GEA (Foundation Year, Company Profile and etc.)
-
Table GEA Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table GEA Insulin Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Insulin Product and Service
-
Table United Laboratories (TUL) (Foundation Year, Company Profile and etc.)
-
Table United Laboratories (TUL) Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table United Laboratories (TUL) Insulin Product and Service
-
Table Emisphere (Foundation Year, Company Profile and etc.)
-
Table Emisphere Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emisphere Insulin Product and Service
-
Table MannKind (Foundation Year, Company Profile and etc.)
-
Table MannKind Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table MannKind Insulin Product and Service
-
Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Insulin Product and Service
-
Table Gan & Lee (Foundation Year, Company Profile and etc.)
-
Table Gan & Lee Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gan & Lee Insulin Product and Service
-
Table Disha Pharmaceutical Group (Foundation Year, Company Profile and etc.)
-
Table Disha Pharmaceutical Group Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Disha Pharmaceutical Group Insulin Product and Service
-
